Are preoperative FDG-PET/CT scans being done in patients undergoing pancreatic cancer surgery: an audit at a single UK hospital between 2018 and 2022

      Introduction: Pancreatic cancer is the tenth most common cancer in The UK. Over 33% of patients have distant metastasis at diagnosis [1]. NICE guideline [NG85] states that patients with pancreatic cancer having surgery should undergo pre-operative FDG-PET/CT (PET-CT) for staging [2]. A study by Farma et al showed 11% of patients with pancreatic cancer had a change to their management as PET-CT detected metastasis not identified by standard protocols [3]. This audit assessed if patients were undergoing a preoperative PET-CT as per NICE guidelines.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to European Journal of Surgical Oncology
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect